| Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens K Kavanagh, EP Reeves FEMS microbiology reviews 28 (1), 101-112, 2004 | 490 | 2004 |
| Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae M Brennan, DY Thomas, M Whiteway, K Kavanagh FEMS Immunology & Medical Microbiology 34 (2), 153-157, 2002 | 414 | 2002 |
| Fungi: biology and applications K Kavanagh John Wiley & Sons, 2017 | 410 | 2017 |
| Mite‐related bacterial antigens stimulate inflammatory cells in rosacea N Lacey, S Delaney, K Kavanagh, FC Powell British Journal of Dermatology 157 (3), 474-481, 2007 | 394 | 2007 |
| An analysis of the structural and functional similarities of insect hemocytes and mammalian phagocytes N Browne, M Heelan, K Kavanagh Virulence 4 (7), 597-603, 2013 | 325 | 2013 |
| Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs) CP Duffy, CJ Elliott, RA O’Connor, MM Heenan, S Coyle, IM Cleary, ... European journal of cancer 34 (8), 1250-1259, 1998 | 302 | 1998 |
| Superoxide Production in Galleria mellonella Hemocytes: Identification of Proteins Homologous to the NADPH Oxidase Complex of Human Neutrophils D Bergin, EP Reeves, J Renwick, FB Wientjes, K Kavanagh Infection and immunity 73 (7), 4161-4170, 2005 | 293 | 2005 |
| Histatins: antimicrobial peptides with therapeutic potential K Kavanagh, S Dowd Journal of pharmacy and pharmacology 56 (3), 285-289, 2004 | 292 | 2004 |
| Development of an insect model for the in vivo pathogenicity testing of yeasts G Cotter, S Doyle, K Kavanagh FEMS Immunology & Medical Microbiology 27 (2), 163-169, 2000 | 288 | 2000 |
| Anticancer and antifungal activity of copper (II) complexes of quinolin-2 (1H)-one-derived Schiff bases BS Creaven, B Duff, DA Egan, K Kavanagh, G Rosair, VR Thangella, ... Inorganica Chimica Acta 363 (14), 4048-4058, 2010 | 263 | 2010 |
| Potential role of Demodex mites and bacteria in the induction of rosacea S Jarmuda, N O’Reilly, R Żaba, O Jakubowicz, A Szkaradkiewicz, ... Journal of medical microbiology 61 (11), 1504-1510, 2012 | 257 | 2012 |
| Under the lash: Demodex mites in human diseases N Lacey, K Kavanagh, SCG Tseng The biochemist 31 (4), 20-24, 2009 | 241 | 2009 |
| Candida Urinary Tract Infections—Treatment JF Fisher, JD Sobel, CA Kauffman, CA Newman Clinical infectious diseases 52 (suppl_6), S457-S466, 2011 | 231 | 2011 |
| Correlation between Gliotoxin Production and Virulence of Aspergillus fumigatus in Galleria mellonella EP Reeves, CGM Messina, S Doyle, K Kavanagh Mycopathologia 158, 73-79, 2004 | 224 | 2004 |
| Candida Urinary Tract Infection: Pathogenesis JF Fisher, K Kavanagh, JD Sobel, CA Kauffman, CA Newman Clinical Infectious Diseases 52 (suppl_6), S437-S451, 2011 | 198 | 2011 |
| Self-Protection against Gliotoxin—A Component of the Gliotoxin Biosynthetic Cluster, GliT, Completely Protects Aspergillus fumigatus Against Exogenous Gliotoxin M Schrettl, S Carberry, K Kavanagh, H Haas, GW Jones, J O'Brien, ... PLoS pathogens 6 (6), e1000952, 2010 | 197 | 2010 |
| Mode of anti-fungal activity of 1, 10-phenanthroline and its Cu (II), Mn (II) and Ag (I) complexes B Coyle, K Kavanagh, M McCann, M Devereux, M Geraghty Biometals 16, 321-329, 2003 | 197 | 2003 |
| Innate humoral immune defences in mammals and insects: The same, with differences? G Sheehan, A Garvey, M Croke, K Kavanagh Virulence 9 (1), 1625-1639, 2018 | 188 | 2018 |
| Correlation between ocular Demodex infestation and serum immunoreactivity to Bacillus proteins in patients with facial rosacea J Li, N O'Reilly, H Sheha, R Katz, VK Raju, K Kavanagh, SCG Tseng Ophthalmology 117 (5), 870-877. e1, 2010 | 177 | 2010 |
| Pre-exposure to yeast protects larvae of Galleria mellonella from a subsequent lethal infection by Candida albicans and is mediated by the increased expression of antimicrobial … D Bergin, L Murphy, J Keenan, M Clynes, K Kavanagh Microbes and infection 8 (8), 2105-2112, 2006 | 167 | 2006 |
